ArticleTranslational andrology and urology2026
Transforming postoperative follow-up: telemedicine trends in radical prostatectomy patients.
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic ushered in the widespread adoption of telemedicine in the healthcare landscape. Telemedicine utilization has persisted beyond the pandemic and is considered an acceptable method of surveilling cancer patients. Oncologic surveillance following radical prostatectomy (RP) involves checking serum prostate specific antigen (PSA) and theoretically is well suited for telemedicine. We compare demographic data and clinical traits of patients undergoing in-person Methods: A retrospective cohort study of RP patients for a single surgeon with clinic visits occurring between January 2021-April 2024 was performed. For data entry and analysis, the most recent visit for each unique patient was used even if multiple visits occurred during the study. Patient distance from hospital was calculated using CDXGeoData API software and representative map produced on Google Maps. For bivariate statistical analysis, Wilcoxon Rank Sum test was used for continuous variables and Chi-squared and two sampled Results: Four hundred and ninety-one patients were included of which 283 (58%) visits were in-person and 208 (42%) were telemedicine. On bivariate analysis, compared to in-person visits, patients utilizing telemedicine lived a greater distance from the hospital (P<0.001). Race was significantly associated with visit modality (P=0.046), with White patients demonstrating higher utilization of telemedicine. In contrast, cancer recurrence (P=0.04) and active androgen deprivation therapy (ADT) use (P=0.01) were significantly associated with in-person encounters. Erectile dysfunction (ED), stress urinary incontinence (SUI), marital status, pathologic stage, and PSA nadir were not significantly associated with visit type. On multivariate analysis, only younger age [odds ratio (OR) 0.846, 95% confidence interval (CI): 0.742-0.964] and White race (OR 0.406, 95% CI: 0.182-0.907) were independently associated with telemedicine use. Conclusions: Telemedicine offers an effective and patient centric method of surveillance after RP. Targeted efforts are needed to address sociodemographic factors that influence its utilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.